TNGX compared with IMVT: revenue, margins and what each company keeps, and the suppliers and customers both name

TNGXTango Therapeutics, Inc.

Mkt capRevenueRevenue

IMVTImmunovant, Inc.

Mkt capRevenueRevenue

Compare

TNGXTango Therapeutics, Inc.

IMVTImmunovant, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

TNGXTango Therapeutics, Inc.

22.84▲+0.54%

Mkt cap$3.8BRevenue$54MQ3 FY25Revenue$42MFY24

IMVTImmunovant, Inc.

29.31▲+0.47%

Regular sessionSep 2 '83

Mkt cap$6.0BRevenue—Revenue—

Compare

Regular sessionSep 2 '83

TNGXTango Therapeutics, Inc.

IMVTImmunovant, Inc.

22.84▲+0.54%

Price

29.31▲+0.47%

$3.8B

Mkt cap

$6.0B

Q3 FY25$54M

Revenue

—

FY24$42M

Revenue

—

TNGX22.84▲+0.54%vsIMVT29.31▲+0.47%Regular sessionSep 2 '83

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

IMVT: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only TNGX 1

—WuXi AppTecunlistedsupplier

Shared 0

No shared counterparties.

Only IMVT 4

ROIVRoivant Sciencessupplier

—Ypsomedunlistedsupplier

—Roivant Sciences GmbHunlistedsupplier

—

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

HanAll

unlistedsupplier

Price

rebased to 0%

TNGX, solidIMVT, dashed